2nd Quarter - Report

AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOOD & BIOTHERAPIES for AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOO

Firm
Client
Income
—
Expenses
—

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Advancing policies that support the blood supply.

LobbyistCovered position, as disclosed
SUSAN LEPPKE New —
LEAH MENDELSOHN STONE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Support for innovative payment models for novel biotherapies.

LobbyistCovered position, as disclosed
SUSAN LEPPKE —
LEAH MENDELSOHN STONE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

Appropriations for the Center for Biologics Evaluation and Research at the Food and Drug Administration in the FY 2022 appropriations bill for the Departments of Agriculture, Rural Development, Food and Drug Administration, and Related Agencies. Appropriations for implementation of section 3226 of the Coronavirus Aid, Relief, and Economic Security Act (P.L. 116-136)

LobbyistCovered position, as disclosed
SUSAN LEPPKE —
LEAH MENDELSOHN STONE New —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.